Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy, study finds 0 24.07.2024 03:48 Sciencedaily.com Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
